Literature DB >> 11300962

Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996.

J López-Zetina1, P Kerndt, W Ford, T Woerhle, M Weber.   

Abstract

AIMS: To describe injection risk behaviors while in detention in a sample of injection drug users (IDUs) in Los Angeles County. DESIGN AND
SETTING: Cross-sectional, interviewer-administered, face-to-face risk survey, and serological screening for HIV and hepatitis B conducted at four street locations in Los Angeles County between 1994 and 1996. All interviews were conducted in a non-institutionalized setting. MEASUREMENTS: Ascertainment of self-reported risk behavior during detention and screening for HIV and hepatitis B surface antigen (HBsAg) and antibody to the core (HBcAb) seromarkers. PARTICIPANTS: Six hundred and forty-two participants were street-recruited during the study period. Seventy-one per cent of the sample was male, the median age was 43 years, 61% were African-American, 27% were Latino, 8% were white and 36% considered themselves homeless.
FINDINGS: Overall HIV prevalence was 3.0%; 3.1% tested positive for the hepatitis B surface antigen marker (HBsAg), and 80.3% for antibody to hepatitis B core antigen (HBcAb). After adjustment for length of injection drug use and recency of release from detention, HIV seroreactivity was significantly associated with history of detention due to possession of IDU paraphernalia (OR = 1.9). The presence of the hepatitis B HBcAb seromarker was associated with injection drug use while in detention, (OR = 1.7), and having been ever arrested for possession of IDU paraphernalia (OR = 1.8).
CONCLUSIONS: IDU detainees constitute a high risk group for blood-borne infections. Comprehensive prevention and health promotion efforts in the community need to include correctional facilities.

Entities:  

Mesh:

Year:  2001        PMID: 11300962     DOI: 10.1080/09652140020031638

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  14 in total

1.  HIV among injection drug users in large US metropolitan areas, 1998.

Authors:  Samuel R Friedman; Spencer Lieb; Barbara Tempalski; Hannah Cooper; Marie Keem; Risa Friedman; Peter L Flom
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

2.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.

Authors:  Stephanie R Bialek; William A Bower; Karen Mottram; Dave Purchase; T Nakano; Omana Nainan; Ian T Williams; Beth P Bell
Journal:  J Urban Health       Date:  2005-07-27       Impact factor: 3.671

Review 3.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

4.  Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users.

Authors:  J D Rich; B J Anderson; B Schwartzapfel; M D Stein
Journal:  Epidemiol Infect       Date:  2005-09-30       Impact factor: 2.451

5.  Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France.

Authors:  L Verneuil; J-S Vidal; R Ze Bekolo; A Vabret; J Petitjean; R Leclercq; D Leroy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-08       Impact factor: 3.267

6.  Limited infection with occult hepatitis B virus in drug users in the USA.

Authors:  Jason T Blackard; Christina M Martin; Satarupa Sengupta; Janet Forrester
Journal:  Hepatol Res       Date:  2012-08-22       Impact factor: 4.288

7.  Applying classification and regression tree analysis to identify prisoners with high HIV risk behaviors.

Authors:  Linda Frisman; Michael Prendergast; Hsiu-Ju Lin; Eleni Rodis; Lisa Greenwell
Journal:  J Psychoactive Drugs       Date:  2008-12

8.  Economic evaluation of delivering hepatitis B vaccine to injection drug users.

Authors:  Yiqing Hu; Lauretta E Grau; Greg Scott; Karen H Seal; Patricia A Marshall; Merrill Singer; Robert Heimer
Journal:  Am J Prev Med       Date:  2008-07       Impact factor: 5.043

9.  The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.

Authors:  F-C Tseng; B R Edlin; M Zhang; A Kral; M P Busch; B A Ortiz-Conde; T M Welzel; T R O'Brien
Journal:  J Viral Hepat       Date:  2008-05-27       Impact factor: 3.728

10.  Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.

Authors:  Fan-Chen Tseng; Thomas R O'Brien; Mingdong Zhang; Alex H Kral; Betty A Ortiz-Conde; Jennifer Lorvick; Michael P Busch; Brian R Edlin
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.